Login to Your Account



NewCo News: Kite Pharma Plans to Develop Immune System-Based Drugs

By Catherine Shaffer


Monday, May 9, 2011
Kite Pharma Inc. is a new company created to pursue what its leadership described as "the next therapeutic modality" in treating cancer: recruiting the body's own immune system to fight malignancies. Its pipeline of immunotherapeutic candidates combines tumor-specific antigens and targeted immune-activating components.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription